Scientists are continuing to find evidence that GLP-1 medications can temper cravings for alcohol and other drugs.

Individuals who take liraglutide or semaglutide for weight loss reduce their alcohol consumption by almost two-thirds in four ...

Weight loss drugs could “revolutionise the treatment of alcohol use disorder” by “effortlessly” slashing the amount that ...

It's been explained what happens if you take just one dose of Ozempic and how long the treatment stays in your system.

Drugs like Ozempic — which mimic the appetite-suppressing GLP-1 hormone the body naturally produces after eating — have been ...

FAT jabs like Mounjaro and Wegovy could slash boozing by two-thirds, a study has shown. It’s not the first time the weight ...

A conference poster presented at the European Congress on Obesity (ECO) looks at weight loss drugs (GLP-1s) and reduced alcohol intake. Prof Kevin McConway, Emeritus Professor of Applied Statistics, ...

Adverse reactions to weight-loss jabs are set to soar by more than 350% in a single year, according to the latest data.

Naim Alkhouri, MD, spoke to the potential for glucagon-like peptide-1 (GLP-1) receptor agonists to transform the treatment landscape for patients with metabolic dysfunction-associated steatohepatitis ...

Semaglutides could help treat alcohol use disorder, which has a notoriously high relapse rate.

Weight loss jabs could help slash alcohol intake in obese people by around two thirds, according to a study. It is thought ...

Individuals who take liraglutide or semaglutide for weight loss reduce their alcohol consumption by almost two-thirds in four months, new research ...